PYC Therapeutics Limited (ASX:PYC)
Australia · Delayed Price · Currency is AUD 1.155
+0.090 (8.45%)
Apr 8, 2026, 11:39 AM AEST
PYC Therapeutics Market Cap
PYC Therapeutics has a market cap or net worth of 1.05 billion as of April 7, 2026. Its market cap has increased by 68.02% in one year.
Market Cap
1.05B
Enterprise Value
927.45M
Revenue
20.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.16
Market Cap Chart
Since March 30, 2005, PYC Therapeutics's market cap has increased from 28.04M to 1.05B, an increase of 3,633.95%. That is a compound annual growth rate of 18.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.10B | 13.58% |
| Dec 31, 2025 | 965.30M | 56.72% |
| Dec 31, 2024 | 615.92M | 50.00% |
| Dec 29, 2023 | 410.62M | 87.08% |
| Dec 30, 2022 | 219.48M | -48.89% |
| Dec 31, 2021 | 429.43M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.39B |
| Mesoblast | 2.75B |
| Neuren Pharmaceuticals | 1.52B |
| Clarity Pharmaceuticals | 1.17B |
| Opthea | 738.77M |
| Racura Oncology | 479.29M |
| Clinuvel Pharmaceuticals | 452.81M |
| Tetratherix | 220.32M |